{"id":"W6927423988","doi":"10.3205/18dgrh176","title":"5 years of Secukinumab – high sustained efficacy and favorable safety in psoriasis patients with psoriatic arthritis at baseline","year":2019,"lang":"en","type":"article","venue":"German Medical Science (German Research Foundation)","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"XLV Diagnostics (Canada); Probity Medical Research; Innovaderm (Canada)","funders":"","keywords":"Secukinumab; Psoriatic arthritis; Psoriasis; Monoclonal antibody; Arthritis; Adverse effect; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001223245,0.0003131014,0.0008452805,0.0002126851,0.0005052824,0.0007660362,0.0001857654,0.000596631,0.003273308],"category_scores_gemma":[0.0009531729,0.000123842,0.0008886297,0.0003107242,0.0002315543,0.0005242822,0.0002467727,0.001183689,0.0007916583],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003915406,"about_ca_system_score_gemma":0.0005625871,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001096714,"about_ca_topic_score_gemma":0.001897343,"domain_scores_codex":[0.9995381,0.0001098756,0.00003622434,0.00008219057,0.00006131592,0.0001722957],"domain_scores_gemma":[0.9992392,0.0001014239,0.0001563184,0.00006237984,0.0001005376,0.000340169],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.1656487,0.01551296,0.1687138,0.0009902217,0.003913832,0.001690021,0.0006011101,0.002574066,0.02960193,0.0007060125,0.0144054,0.595642],"study_design_scores_gemma":[0.01318293,0.3051717,0.6423482,0.0003093525,0.00277433,0.002410533,0.0002479622,0.001731259,0.004118476,0.0006221961,0.02698382,0.00009922227],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9741479,0.01634449,0.0006716128,0.001192123,0.0003305534,0.0001238205,0.001127401,0.0001286331,0.005933384],"genre_scores_gemma":[0.9946486,0.001526793,0.0001600047,0.000908579,0.000157023,0.00005149181,0.001058204,0.000007935138,0.001481435],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003273308,"threshold_uncertainty_score":0.01095033,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01314409996503122,"score_gpt":0.3024600288708942,"score_spread":0.289315928905863,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}